Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling
Tóm tắt
Từ khóa
Tài liệu tham khảo
Maron, 2002, Hypertrophic cardiomyopathy: a systematic review, JAMA, 287, 1308, 10.1001/jama.287.10.1308
Cambronero, 2009, Biomarkers of pathophysioloy in hypertrophic cardiomyopathy: implications for clinical management and prognosis, Eur Heart J, 30, 139, 10.1093/eurheartj/ehn538
Spinale, 2002, Matrix metalloproteinases: regulation and dysregulation in the failing heart, Circ Res, 9, 520, 10.1161/01.RES.0000013290.12884.A3
Lombardi, 2003, Myocardial collagen turnover in hypertrophic cardiomyopathy, Circulation, 108, 1455, 10.1161/01.CIR.0000090687.97972.10
Noji, 2004, Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction, Circ J, 68, 355, 10.1253/circj.68.355
Roldán, 2008, Matrix metalloproteinases and tissue remodelling in hypertrophic cardiomyopathy, Am Heart J, 156, 85, 10.1016/j.ahj.2008.01.035
Briguori, 2001, Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy, Eur Heart J, 22, 1328, 10.1053/euhj.2000.2535
Maron, 2004, Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy, Circulation, 109, 984, 10.1161/01.CIR.0000117098.75727.D8
Payá, 2008, Variables associated with gadolinium-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications, J Cardiac Fail, 14, 414, 10.1016/j.cardfail.2008.02.006
Tsuruda, 2002, Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases, Circ Res, 9, 1127, 10.1161/01.RES.0000046234.73401.70
May, 2006, Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure, Am J Cardiol, 98, 653, 10.1016/j.amjcard.2006.03.046
Gach, 2007, Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris, Am J Cardiol, 99, 31, 10.1016/j.amjcard.2006.07.059
Siirila-Waris, 2006, Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure, Eur Heart J, 27, 3011, 10.1093/eurheartj/ehl407
Abhayaratna, 2006, Left atrial size: physiologic determinants and clinical applications, J Am Coll Cardiol, 47, 2357, 10.1016/j.jacc.2006.02.048
Paulus, 2007, How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology, Eur Heart J, 28, 2539, 10.1093/eurheartj/ehm037
Khankirawatana, 2004, How should left atrial size be reported? Comparative assessment with use of multiple echocardiographic methods, Am Heart J, 147, 369, 10.1016/j.ahj.2003.03.001
Buchner, 2008, Left atrial size by planimetry is superior to m-mode diameter: biochemical calibration by atrial and brain natriuretic peptide, J Am Soc Echocardiogr, 21, 380, 10.1016/j.echo.2007.06.006
Yang, 2005, Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity, J Am Soc Echocardiogr, 18, 1074, 10.1016/j.echo.2005.06.011
Sachdev, 2005, Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy, Am Heart J, 149, 730, 10.1016/j.ahj.2004.07.017
Tani, 2004, Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy, J Am Soc Echocardiogr, 17, 644, 10.1016/j.echo.2004.02.010
McKenna, 1997, Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families, Heart, 77, 130, 10.1136/hrt.77.2.130
Lang, 2006, Recommendations for chamber quantification, Eur J Echocardiogr, 7, 79, 10.1016/j.euje.2005.12.014
Fox, 2007, Report on the European Association of Echocardiography accreditations in echocardiography: December 2003-September 2006, Eur J Echocardiogr, 8, 74, 10.1016/j.euje.2006.11.001
Gehan, 1970, Estimation of human body surface area from height and weight, Cancer Chemother Rep, 54, 225
Maron, 1987, Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, 10, 733, 10.1016/S0735-1097(87)80264-4
Nihoyannopoulos, 1992, Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity, J Am Coll Cardiol, 19, 536, 10.1016/S0735-1097(10)80268-2
Jassal, 2006, Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy, Eur Heart J, 27, 1805, 10.1093/eurheartj/ehl106
Jiamsripong, 2008, Three methods for evaluation of left atrial volume, Eur J Echocardiogr, 9, 351
Kjaergaard, 2005, Left atrial index is a predictor of exercise capacity in patients with hypertrophic cardiomyopathy, J Am Soc Echocardiogr, 18, 1373, 10.1016/j.echo.2005.05.020
Thaman, 2006, Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy, Am J Cardiol, 98, 515, 10.1016/j.amjcard.2006.02.057
Boos, 2006, Is atrial fibrillation an inflammatory disorder?, Eur Heart J, 27, 136, 10.1093/eurheartj/ehi645
Issac, 2007, Role of inflammation in initiation and perpetuation of atrial fibrillation. A systematic review of the published data, J Am Coll Cardiol, 50, 2021, 10.1016/j.jacc.2007.06.054
Boos, 2008, Inflammation and atrial fibrillation: cause or effect?, Heart, 94, 133, 10.1136/hrt.2007.119651
Yamazaki, 2004, Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure, Eur J Heart Fail, 6, 41, 10.1016/j.ejheart.2003.05.002
Thaman, 2004, Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy, J Am Coll Cardiol, 44, 398, 10.1016/j.jacc.2004.01.054